Phase II trial of edatrexate in patients with metastatic colorectal cancer

Investigational New Drugs

Volumn 13, Issue 4, 1995, Pages 359-361

  Clamon, Gerald H ^a   Riggs Jr , Charles E ^a   Dreicer, Robert ^a   Hohl, Raymond J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

colon cancer; edatrexate

Indexed keywords

EDATREXATE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; VOMITING; XENOGRAFT;

AGED; AMINOPTERIN; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0029582628     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/BF00873145     Document Type: Article

References (9)

1. New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties
2. New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic fluid and solid murine tumor modules
3. New folate analogs of the 10-deaza-aminopterin series. Markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in mice
4. Methotrexate therapy with or without citrovorum factor in carcinoma of the head and neck, breast or colon
5. Comparison of antimetabolites in the treatment of breast and colon cancer
6. For the Arbeitsgemeinschaft Internistische Onkologie. Sequential Methotrexate and 5-Fluorouracil: Improved response rate in metastatic colorectal cancer
7. Sequential therapy with Methotrexate and 5-Fluorouracil in the treatment of advanced colorectal carcinoma
8. Phase II trial of 10-Edam in patients with advanced colorectal carcinoma